126 related articles for article (PubMed ID: 38663484)
21. Paracrine effects of human amniotic epithelial cells protect against chemotherapy-induced ovarian damage.
Zhang Q; Bu S; Sun J; Xu M; Yao X; He K; Lai D
Stem Cell Res Ther; 2017 Nov; 8(1):270. PubMed ID: 29179771
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
23. Cyclophosphamide promotes the proliferation inhibition of mouse ovarian granulosa cells and premature ovarian failure by activating the lncRNA-Meg3-p53-p66Shc pathway.
Xiong Y; Liu T; Wang S; Chi H; Chen C; Zheng J
Gene; 2017 Jan; 596():1-8. PubMed ID: 27729272
[TBL] [Abstract][Full Text] [Related]
24. A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma.
Ilyas SI; Yamada D; Hirsova P; Bronk SF; Werneburg NW; Krishnan A; Salim W; Zhang L; Trushina E; Truty MJ; Gores GJ
J Biol Chem; 2016 Apr; 291(15):8031-47. PubMed ID: 26826125
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury.
Chen J; Wang X; He Q; Yang HC; Fogo AB; Harris RC
Kidney Int; 2024 Jun; 105(6):1200-1211. PubMed ID: 38423183
[TBL] [Abstract][Full Text] [Related]
26. Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice.
Wang Z; Wang Y; Yang T; Li J; Yang X
Stem Cell Res Ther; 2017 Jan; 8(1):11. PubMed ID: 28114977
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 dependent modulation of Hippo pathway in cancer cells.
D'Aguanno S; Brignone M; Scalera S; Chiacchiarini M; Di Martile M; Valentini E; De Nicola F; Ricci A; Pelle F; Botti C; Maugeri-Saccà M; Del Bufalo D
Cell Commun Signal; 2024 May; 22(1):277. PubMed ID: 38755629
[TBL] [Abstract][Full Text] [Related]
28. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
[TBL] [Abstract][Full Text] [Related]
29. Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP.
Palamiuc L; Johnson JL; Haratipour Z; Loughran RM; Choi WJ; Arora GK; Tieu V; Ly K; Llorente A; Crabtree S; Wong JCY; Ravi A; Wiederhold T; Murad R; Blind RD; Emerling BM
Sci Signal; 2024 May; 17(838):eado6266. PubMed ID: 38805583
[TBL] [Abstract][Full Text] [Related]
30. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
31. Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway.
Dong L; Lin F; Wu W; Liu Y; Huang W
Int J Med Sci; 2018; 15(6):645-652. PubMed ID: 29725256
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation.
Grosbois J; Demeestere I
Hum Reprod; 2018 Sep; 33(9):1705-1714. PubMed ID: 30032281
[TBL] [Abstract][Full Text] [Related]
33. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
[TBL] [Abstract][Full Text] [Related]
34. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
35. Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Improve Ovarian Function and Proliferation of Premature Ovarian Insufficiency by Regulating the Hippo Signaling Pathway.
Li Z; Zhang M; Zheng J; Tian Y; Zhang H; Tan Y; Li Q; Zhang J; Huang X
Front Endocrinol (Lausanne); 2021; 12():711902. PubMed ID: 34456868
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-22-3p in human umbilical cord mesenchymal stem cell-secreted exosomes inhibits granulosa cell apoptosis by targeting KLF6 and ATF4-ATF3-CHOP pathway in POF mice.
Gao T; Chen Y; Hu M; Cao Y; Du Y
Apoptosis; 2023 Aug; 28(7-8):997-1011. PubMed ID: 37000316
[TBL] [Abstract][Full Text] [Related]
37. Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway.
Sa P; Singh P; Panda S; Swain RK; Dash R; Sahoo SK
Transl Res; 2024 Jun; 268():63-78. PubMed ID: 38499286
[TBL] [Abstract][Full Text] [Related]
38. Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity.
Peng L; Zhou L; Li H; Zhang X; Li S; Wang K; Yang M; Ma X; Zhang D; Xiang S; Duan Y; Wang T; Sun C; Wang C; Lu D; Qian M; Wang Z
Cell Rep; 2024 Apr; 43(4):114003. PubMed ID: 38527062
[TBL] [Abstract][Full Text] [Related]
39. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
[TBL] [Abstract][Full Text] [Related]
40. FTO protects human granulosa cells from chemotherapy-induced cytotoxicity.
Wang R; Wang W; Wang L; Yuan L; Cheng F; Guan X; Zheng N; Yang X
Reprod Biol Endocrinol; 2022 Feb; 20(1):39. PubMed ID: 35219326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
